A randomized, open-label clinical trial to evaluate immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Easyfour®-TT) with Quadrovax® in Indian infants

An open-label, randomized, multi-center trial was conducted to compare the immunogenicity and safety of an indigenously developed tetravalent DTwP-Hib vaccine, Easyfour®-TT with a commercially available vaccine, Quadrovax®. A total of 244 infants in good health, aged 6–10 weeks, were randomized in a...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Lalitendu Mohanty, Sunil Sharma, Beauty Behera, Sachin Panwar, Charu Paliwal, Anit Singh, Anu Gupta, Deepak Chandra Chilkoti
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2017-09-01
Colecção:	Human Vaccines & Immunotherapeutics
Assuntos:	combination dtwp-hib easyfour®-tt seroprotection tetravalent vaccine
Acesso em linha:	http://dx.doi.org/10.1080/21645515.2017.1342020
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!